Maze director granted 33,417 stock options
Maze Therapeutics director Neil Kumar received a grant of stock options to buy 33,417 shares of Common Stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Maze Therapeutics director Neil Kumar received a grant of stock options to buy 33,417 shares of Common Stock. The options carry an exercise price of $30.38 per share and expire on March 26, 2036. They vest in 36 equal monthly installments starting April 27, 2026, contingent on his continued service.
Insider Trade Summary
Grant/Award: 33,417 shares
Grant/Award
1 txn
Insider
Kumar Neil
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 33,417 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 33,417 contracts (Direct)
Footnotes (1)
- F1. The option shall vest as to 1/36th of the total award monthly, with the first tranche vesting on April 27, 2026, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
Key Figures
Options granted: 33,417 options
Exercise price: $30.38 per share
Expiration date: March 26, 2036
+1 more
4 metrics
Options granted
33,417 options
Grant of Stock Option (Right to Buy)
Exercise price
$30.38 per share
Stock option exercise price
Expiration date
March 26, 2036
Option expiration
Post-transaction derivative holdings
33,417 options
Total derivative securities following grant
Key Terms
Stock Option (Right to Buy), exercise price, expiration date, vesting, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 30.3800"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-03-26T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"The option shall vest as to 1/36th of the total award monthly"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Maze Therapeutics (MAZE) report for Neil Kumar?
Maze Therapeutics reported that director Neil Kumar received a grant of stock options for 33,417 shares of Common Stock. The options are a compensation-related award, not an open-market purchase or sale, and give him the right to buy shares at a fixed exercise price.
How many Maze Therapeutics (MAZE) stock options were granted to Neil Kumar?
Neil Kumar was granted stock options covering 33,417 shares of Maze Therapeutics Common Stock. These options give him the right to purchase that number of shares at a predetermined exercise price, subject to the vesting schedule and his continued service with the company.
What is the exercise price and expiration date of Neil Kumar’s Maze (MAZE) options?
The granted stock options have an exercise price of $30.38 per share and expire on March 26, 2036. This means Kumar can choose to buy shares at $30.38 any time after vesting and before the March 26, 2036 expiration date.
How do Neil Kumar’s Maze Therapeutics (MAZE) options vest over time?
The options vest in 36 equal monthly installments, with the first 1/36th vesting on April 27, 2026. Each remaining tranche vests on the monthly anniversary, provided Neil Kumar continues to serve Maze Therapeutics on each respective vesting date.
Is Neil Kumar’s Maze (MAZE) Form 4 transaction a market purchase or sale?
The Form 4 shows a grant of stock options as compensation, coded as a grant or award acquisition. It is not an open-market purchase or sale of existing Maze Therapeutics shares, but a right to buy shares in the future at a fixed price.
AI-generated analysis. How Rhea-AI works. Not financial advice.
